Target intelligence / Profile preview

Serine beta-lactamase class D (OXA-type beta-lactamase)

Target
OXA-type beta-lactamase
Molecular classification
Enzyme, Hydrolase (EC 3.5.2.6), Serine beta-lactamase (class D; molecular class D in Ambler classification), Beta-lactamase family protein
01

Overview

Class D serine beta-lactamases (often termed OXA-type beta-lactamases) are bacterial enzymes that hydrolyze the amide bond of the beta-lactam ring in penicillins, cephalosporins, cephamycins, monobactams, and for some variants carbapenems, thereby inactivating these antibiotics and conferring resistance. They belong to the serine beta-lactamase superfamily (Ambler molecular class D) that uses an active-site serine for catalysis and are grouped functionally within group 2 serine beta-lactamases alongside class A enzymes. Structural studies of a prototypical member, OXA-10, show an alpha/beta fold related to classes A and C but with distinct active-site features and catalytic base arrangement, indicating a mechanistically distinct serine-dependent hydrolysis pathway within class D. These enzymes likely evolved from DD-transpeptidases (penicillin-binding proteins), the native targets of beta-lactam antibiotics, and enable bacteria—often Gram-negative species that can secrete these enzymes—to survive beta-lactam exposure, driving clinically significant antimicrobial resistance.

Other names
Class D beta-lactamaseOXA beta-lactamaseOXA-type serine beta-lactamaseClass D serine beta-lactamase
02

Mechanism of action

Serine-dependent hydrolysis: formation of an acyl-enzyme intermediate via active-site serine followed by deacylation to open the beta-lactam ring and inactivate the antibiotic. Distinct class D catalytic features: class D enzymes share the alpha/beta fold with classes A and C but employ a distinct catalytic base arrangement; structural studies (e.g., OXA-10) indicate differences from class A (Glu166) and class C (Tyr150) general base roles, implying a distinct catalytic mechanism within serine beta-lactamases.

03

Biological functions

Hydrolysis of the beta-lactam ring of beta-lactam antibioticsAntibiotic resistance mechanism in bacteria (inactivation of beta-lactams)Maintenance of bacterial survival under beta-lactam exposure (counteracting PBP inhibition)
04

Disease associations

Infection (bacterial drug resistance leading to difficult-to-treat infections)Other: Healthcare-associated and community-acquired bacterial resistance phenotypes via ESBLs and serine carbapenemases within group 2 enzymes
05

Safety considerations

Therapeutic challenge: enzymatic resistance reduces efficacy of multiple beta-lactam classes, narrowing treatment optionsPotential carbapenem hydrolysis by some class D enzymes (serine carbapenemases), compromising last-line agentsLimited potency of some classical inhibitors against class D enzymes, complicating inhibitor-based therapies
06

Interacting drugs

Beta-lactam antibiotics (substrates hydrolyzed/inactivated): penicillins, cephalosporins, cephamycins, monobactams; some class D enzymes also act on carbapenems

2 more in the full profile.

07

Biomarkers

Presence of class D beta-lactamase genes (e.g., OXA-type gene detection by PCR) as a marker of beta-lactam resistance in clinical isolates (inferred from classification/use in resistance surveillance; functional grouping ties enzyme presence to phenotype)Nitrocefin hydrolysis as a phenotypic marker of beta-lactamase activity

Beyond the preview

Go deeper on Serine beta-lactamase class D (OXA-type beta-lactamase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine beta-lactamase class D (OXA-type beta-lactamase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call